Using Urine Output Trending for the Management of Acute Cardiorenal Syndrome

Anna Rozenfeld1, Aliza Goldman2, Tal Stern2

  • 1Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Insights

Real-time urinary output monitoring in acute decompensated heart failure (ADHF) patients improves fluid balance and reduces acute kidney injury (AKI). This early intervention strategy leads to better clinical outcomes and faster AKI resolution.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Acute decompensated heart failure (ADHF) frequently leads to cardiorenal syndrome (CRS), characterized by worsening kidney function.
  • Type I CRS is associated with increased mortality, prolonged hospitalization, and higher readmission rates in ADHF patients.

Purpose of the Study:

  • To evaluate the impact of continuous urinary output (UO) monitoring on personalized treatment strategies in ADHF patients.
  • To assess the effect of real-time UO monitoring on fluid balance and clinical outcomes within a cardiac intensive care unit setting.

Main Methods:

  • A cohort of 35 ADHF patients underwent continuous UO monitoring (UOelec).
  • Standard diuretic and fluid protocols were initiated after 2 hours of oliguria.
  • Outcomes, including fluid balance and acute kidney injury (AKI) incidence, were compared to a historical matched control (HMC) group.

Main Results:

  • The UOelec group showed significantly greater negative fluid balance daily and cumulatively (91%) compared to the HMC group (20%).
  • The incidence of AKI was substantially lower in the UOelec group (23%) versus the HMC group (57%).
  • Higher AKI resolution rates and lower peak serum creatinine levels were observed in the UOelec cohort.

Conclusions:

  • Real-time UO monitoring facilitates early detection of oliguria and goal-directed therapeutic adjustments in ADHF.
  • This approach effectively reduces fluid overload (congestion) and promotes earlier resolution of acute kidney injury.
  • Implementing continuous UO monitoring can improve patient outcomes in critical care settings for ADHF.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Regulation of Water Output01:26

Regulation of Water Output

The human body predominantly expels water through the urinary system. On average, an individual generates around 1.5 liters of urine each day. This amount can fluctuate based on how well a person is hydrated, but a critical minimum quantity of urine must be produced to ensure the body's proper functioning. Daily, the kidneys remove 600 to 1200 milliosmoles of dissolved substances, effectively excreting excess minerals and water-soluble toxins such as creatinine, urea, and uric acid from the...
271
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
144